Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Multiple Myeloma

Drugs for Multiple Myeloma
Find financial assistance programs available for multiple myeloma drugs. Read More ›

Tecvayli Received FDA Approval for Patients with Relapsed or Refractory Multiple Myeloma

Living My Life While Dealing with Multiple Myeloma
Thomas Goode always worked out; when he felt an excruciating pain on his left side one day working out, he knew something was wrong and visited a surgeon. After terrible back pain months later and another x-ray and MRI, he was diagnosed with multiple myeloma. Read More ›

Thank You CONQUER Magazine for a Great Article
Sally K. Koski, PhD, RN, expresses her gratitude to CONQUER magazine for the very informative article, “Multiple Myeloma: Navigating the First 90 Days,” which was featured in the April 2022 issue. Read More ›

Contact a Myeloma Coach Through the Myeloma Crowd
Sally Torgeson explains how a myeloma coach can help newly diagnosed patients with the vast array of information, emotional, and financial demands of this type of blood cancer. Read More ›

Targeting a Better Future for Patients with Multiple Myeloma
Christopher Greklek competed in Ironman races and was shocked when he was diagnosed with multiple myeloma. He describes being in and out of remission repeatedly, citing a program seeking to improve patient options. Read More ›

Multiple Myeloma: Navigating the First 90 Days
Nurse navigator and multiple myeloma expert Peg Rummel outlines the steps of dealing with multiple myeloma, including diagnostics, treatment planning, and barriers to care. Read More ›

Carvykti Second CAR T-Cell Therapy FDA Approved for Patients with Multiple Myeloma

Cancer Concerns Drift Away While I Focus on My Painting
While painting this beautifully realistic rendition of a Clam Shack in Cape Cod, Eddie Sutherland was able to step back, focus on his art, and forget his cancer concerns for a while. Read More ›

Navigating Treatment for Multiple Myeloma: Adherence Is Key
A thorough overview of multiple myeloma, including an understanding of treatment options, the importance of patient and doctor communication, and an oncology navigator’s experience treating this form of blood cancer. Read More ›

Page 1 of 10